Business Description
2seventy bio Inc
NAICS : 325412
SIC : 2834
ISIN : US9013841070
Share Class Description:
TSVT: Ordinary SharesDescription
2seventy bio Inc is a cell and gene therapy company focused on the research, development, and commercialization of transformative treatments for cancer. The company operates in a single segment, focusing on researching, developing and commercializing potentially transformative treatments for cancer.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.85 | |||||
| Equity-to-Asset | 0.45 | |||||
| Debt-to-Equity | 1.01 | |||||
| Debt-to-EBITDA | -1.24 | |||||
| Interest Coverage | N/A |
N/A
|
N/A
| |||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | -1.55 | |||||
| Beneish M-Score | -3.15 | |||||
| WACC vs ROIC | ||||||
Growth Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -42.4 | |||||
| 3-Year EBITDA Growth Rate | 9.5 | |||||
| 3-Year EPS without NRI Growth Rate | 9.7 | |||||
| 3-Year FCF Growth Rate | 1.7 | |||||
| 3-Year Book Growth Rate | 16.3 | |||||
| Future 3-5Y Total Revenue Growth Rate | 3.03 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 24.89 | |||||
| 9-Day RSI | 33.91 | |||||
| 14-Day RSI | 39.26 | |||||
| 6-1 Month Momentum % | 94.51 | |||||
| 12-1 Month Momentum % | -41.3 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 3.98 | |||||
| Quick Ratio | 3.98 | |||||
| Cash Ratio | 3.63 | |||||
| Days Sales Outstanding | 101.25 | |||||
| Days Payable | 164.9 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -29.5 | |||||
| Shareholder Yield % | -51.71 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 83.15 | |||||
| Operating Margin % | -215.87 | |||||
| Net Margin % | -216.73 | |||||
| FCF Margin % | -180.03 | |||||
| ROE % | -66.29 | |||||
| ROA % | -32.86 | |||||
| ROIC % | -55.49 | |||||
| ROC (Joel Greenblatt) % | -74.93 | |||||
| ROCE % | -36.61 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 2.17 | |||||
| PB Ratio | 0.84 | |||||
| Price-to-Tangible-Book | 0.87 | |||||
| EV-to-EBIT | -1.2 | |||||
| EV-to-EBITDA | -1.26 | |||||
| EV-to-Forward-EBITDA | -3.49 | |||||
| EV-to-Revenue | 2.59 | |||||
| EV-to-Forward-Revenue | 2.83 | |||||
| EV-to-FCF | -1.44 | |||||
| Earnings Yield (Greenblatt) % | -83.33 | |||||
| FCF Yield % | -82.78 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:TSVT
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
2seventy bio Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 100.387 | ||
| EPS (TTM) ($) | -4.42 | ||
| Beta | 0 | ||
| Volatility % | 159.64 | ||
| 14-Day RSI | 39.26 | ||
| 14-Day ATR ($) | 0.466366 | ||
| 20-Day SMA ($) | 4.9365 | ||
| 12-1 Month Momentum % | -41.3 | ||
| 52-Week Range ($) | 1.535 - 12.69 | ||
| Shares Outstanding (Mil) | 51.31 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
2seventy bio Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
2seventy bio Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
2seventy bio Inc Frequently Asked Questions
What is 2seventy bio Inc(TSVT)'s stock price today?
The current price of TSVT is $4.26. The 52 week high of TSVT is $12.69 and 52 week low is $1.54.
When is next earnings date of 2seventy bio Inc(TSVT)?
The next earnings date of 2seventy bio Inc(TSVT) is 2024-05-03 Est..
Does 2seventy bio Inc(TSVT) pay dividends? If so, how much?
2seventy bio Inc(TSVT) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers